Cube Biotech
Founded 2012 · 59 employees on LinkedIn · 2 known investors
Find your way into Cube Biotech
Cube Biotech develops the NativeMP™ platform, including Cubipol/SMALP copolymers and active full-length membrane protein targets, for isolating, purifying, and studying membrane proteins such as ion channels. It also offers custom protein services and bead functionalization used by research institutions for applications like antibody generation and Cryo-EM structural analysis.
Investors · 2
In the news
Frequently asked questions
- What does Cube Biotech do?
- Cube Biotech develops the NativeMP™ platform, including Cubipol/SMALP copolymers and active full-length membrane protein targets, for isolating, purifying, and studying membrane proteins such as ion channels. It also offers custom protein services and bead functionalization used by research institutions for applications like antibody generation and Cryo-EM structural analysis.
- Who are Cube Biotech's investors?
- Cube Biotech's investors include ARCHIMED Japan, Creathor Ventures.